Geneva, Aug. 17 -- International Clinical Trials Registry received information related to the study (KCT0012421) titled 'Zastaprazan for the prEvention of Upper GI Bleeding in Ischemic Stroke' on Aug. 7.
Study Type: Interventional Study
Study Design:
Primary Purpose : Prevention, Intervention Model : Parallel, Blinding/Masking : Double, Blinding Target : Subject, Investigator, Caregiver, Outcome Accessor, Allocation : RCT
Primary Sponsor: Asan Medical Center
Condition:
Diseases of the circulatory system
Intervention:
Drug : Participants will be randomized in a 1:1 ratio to either the experimental arm (zastaprazan citrate 20 mg) or the placebo control arm.
1) Dose and Duration
Experimental arm: Zastaprazan citrate 20 mg, fixed do...